Cargando…
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Central Nervous System (CNS) diseases, such as Alzheimer's diseases (AD), Parkinson's Diseases (PD), brain tumors, Huntington's disease (HD), and stroke, still remain difficult to treat by the conventional molecular drugs. In recent years, various gene therapies have come into the spo...
Autores principales: | Luo, Meihua, Lee, Leo Kit Cheung, Peng, Bo, Choi, Chung Hang Jonathan, Tong, Wing Yin, Voelcker, Nicolas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475540/ https://www.ncbi.nlm.nih.gov/pubmed/35851766 http://dx.doi.org/10.1002/advs.202201740 |
Ejemplares similares
-
Nanomedicine-based immunotherapy for central nervous system disorders
por: Hanif, Sumaira, et al.
Publicado: (2020) -
Nanomedicine to deliver biological macromolecules for treating COVID-19
por: Wilson, Barnabas, et al.
Publicado: (2022) -
Is nanomedicine still promising?
por: Peiris, Pubudu M., et al.
Publicado: (2011) -
The promise of exosome applications in treating central nervous system diseases
por: Mattingly, Jared, et al.
Publicado: (2021) -
Delivering the power of nanomedicine to patients today
por: Germain, Matthieu, et al.
Publicado: (2020)